# ESBRIET
> **NDA022535** · New Drug Application · Sponsor: LEGACY PHARMA · Approved 2014-10-15
## Drug
- **FDA Application Number:** NDA022535
- **Application type:** New Drug Application
- **Brand name:** ESBRIET
- **Generic name:** Pirfenidone
- **Active ingredients:** PIRFENIDONE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** LEGACY PHARMA
- **First approval:** 2014-10-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022535)
---
*AI Analytics · CC0 1.0*